Source:http://linkedlifedata.com/resource/pubmed/id/10891438
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2000-8-10
|
pubmed:abstractText |
Infusions of donor peripheral blood T cells can induce durable remissions of Epstein-Barr virus (EBV) lymphomas complicating marrow grafts, but they contain alloreactive T cells capable of inducing graft-versus-host disease. EBV-specific T-cell lines or clones avoid this problem but require 30 to 40 days of culture to establish. To accelerate the generation of EBV-specific T cells, we tested whether retroviral vectors, which only integrate in dividing cells, could be used to transduce and select antigen-reactive T cells early after sensitization to autologous EBV-transformed B cells. T cells were transduced with a dicistronic retroviral vector, NIT, which encodes low-affinity nerve growth factor receptor as an immunoselectable marker and herpes simplex virus thymidine kinase as a suicide gene, at different time points after sensitization. EBV-specific cytotoxic T lymphocyte precursor (CTLp) frequencies in purified NIT(+) T-cell fractions transduced on day 8 of culture were comparable to those of EBV-specific T-cell lines cultured for 30 days or more. Alloreactive CTLp frequencies were markedly reduced in the NIT(+) fraction relative to the untransduced T-cell population. NIT(+) fractions transduced on day 8 possessed more CD4(+) T cells than the cell lines at day 30 and exhibited the same selective pattern of reactivity against immunodominant antigens presented by specific HLA alleles. In contrast, T cells transduced with NIT 5 days after stimulation with mitogen and interleukin-2 were relatively depleted of T cells specific for autologous EBV-transformed cells. Thus, retroviral vectors may be used for rapid selection of viral antigen-reactive T cells depleted of alloreactive T cells.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0006-4971
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
96
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
109-17
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10891438-Cytotoxicity, Immunologic,
pubmed-meshheading:10891438-Flow Cytometry,
pubmed-meshheading:10891438-Gene Transfer Techniques,
pubmed-meshheading:10891438-Genetic Vectors,
pubmed-meshheading:10891438-HLA Antigens,
pubmed-meshheading:10891438-Herpesvirus 4, Human,
pubmed-meshheading:10891438-Humans,
pubmed-meshheading:10891438-Lymphocyte Activation,
pubmed-meshheading:10891438-Retroviridae,
pubmed-meshheading:10891438-T-Lymphocytes,
pubmed-meshheading:10891438-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:10891438-Virus Integration
|
pubmed:year |
2000
|
pubmed:articleTitle |
Rapid selection of antigen-specific T lymphocytes by retroviral transduction.
|
pubmed:affiliation |
Bone Marrow Transplant Service, Department of Pediatrics, Memorial Hospital, New York, NY, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|